Serum amyloid A as a marker of ankylosing spondylitis activity

Serum amyloid A protein A (SAA) is a normal serum protein (serving as a precursor of fibrillar tissue protein AA), synthesized in the liver and a rapidly responding marker of the acute phase of inflammation. A constant high concentration of SAA is one of the factors in the development of AA-amyloido...

Full description

Saved in:
Bibliographic Details
Main Authors: K. V. Sakharova, M. V. Cherkasova, Sh. F. Erdes
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-12-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1230
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849338573244858368
author K. V. Sakharova
M. V. Cherkasova
Sh. F. Erdes
author_facet K. V. Sakharova
M. V. Cherkasova
Sh. F. Erdes
author_sort K. V. Sakharova
collection DOAJ
description Serum amyloid A protein A (SAA) is a normal serum protein (serving as a precursor of fibrillar tissue protein AA), synthesized in the liver and a rapidly responding marker of the acute phase of inflammation. A constant high concentration of SAA is one of the factors in the development of AA-amyloidosis. As a rule, secondary amyloidosis develops in patients with long-term and poorly controlled inflammatory diseases, including rheumatic diseases, one of which is ankylosing spondylitis (AS).Objective: to assess the level of SAA in AS patients and its relationship with indicators of disease activity.Patients and methods. The study included 124 patients with AS who met the modified New York 1984 criteria. The disease activity and functional status of patients were assessed according to the recommendations of Russian experts. SAA and CRP, ESR in blood serum were measured in all patients.Results and discussion. The median SAA concentration was 12.5 mg/L [4; 71.6]. Of 124 patients, 31% had SAA levels <5 mg/L and 69% had >5 mg/L. A strong correlation was found between the levels of SAA and CRP (r=0.80, p<0.000001), no significant relationship was found between SAA and ESR (r=0.31, p=0.92). The correlation between the AS activity according to the BASDAI index and SAA was weak (r=0.3, p<0.002), the correlation with ASDAS-CRP was moderate (r=0.54, p<0.00001).Conclusion. A statistically significant relationship was found between SAA and CRP levels, as well as the AS activity indices. Research has shown that SAA can be used as one of the markers of inflammation in AS.
format Article
id doaj-art-ea664b548d2a4c0dbcdcb7c71e716ef4
institution Kabale University
issn 1996-7012
2310-158X
language Russian
publishDate 2021-12-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-ea664b548d2a4c0dbcdcb7c71e716ef42025-08-20T03:44:21ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2021-12-01156727510.14412/1996-7012-2021-6-72-752427Serum amyloid A as a marker of ankylosing spondylitis activityK. V. Sakharova0M. V. Cherkasova1Sh. F. Erdes2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologySerum amyloid A protein A (SAA) is a normal serum protein (serving as a precursor of fibrillar tissue protein AA), synthesized in the liver and a rapidly responding marker of the acute phase of inflammation. A constant high concentration of SAA is one of the factors in the development of AA-amyloidosis. As a rule, secondary amyloidosis develops in patients with long-term and poorly controlled inflammatory diseases, including rheumatic diseases, one of which is ankylosing spondylitis (AS).Objective: to assess the level of SAA in AS patients and its relationship with indicators of disease activity.Patients and methods. The study included 124 patients with AS who met the modified New York 1984 criteria. The disease activity and functional status of patients were assessed according to the recommendations of Russian experts. SAA and CRP, ESR in blood serum were measured in all patients.Results and discussion. The median SAA concentration was 12.5 mg/L [4; 71.6]. Of 124 patients, 31% had SAA levels <5 mg/L and 69% had >5 mg/L. A strong correlation was found between the levels of SAA and CRP (r=0.80, p<0.000001), no significant relationship was found between SAA and ESR (r=0.31, p=0.92). The correlation between the AS activity according to the BASDAI index and SAA was weak (r=0.3, p<0.002), the correlation with ASDAS-CRP was moderate (r=0.54, p<0.00001).Conclusion. A statistically significant relationship was found between SAA and CRP levels, as well as the AS activity indices. Research has shown that SAA can be used as one of the markers of inflammation in AS.https://mrj.ima-press.net/mrj/article/view/1230ankylosing spondylitishla-b27saacrpesrsecondary amyloidosis
spellingShingle K. V. Sakharova
M. V. Cherkasova
Sh. F. Erdes
Serum amyloid A as a marker of ankylosing spondylitis activity
Современная ревматология
ankylosing spondylitis
hla-b27
saa
crp
esr
secondary amyloidosis
title Serum amyloid A as a marker of ankylosing spondylitis activity
title_full Serum amyloid A as a marker of ankylosing spondylitis activity
title_fullStr Serum amyloid A as a marker of ankylosing spondylitis activity
title_full_unstemmed Serum amyloid A as a marker of ankylosing spondylitis activity
title_short Serum amyloid A as a marker of ankylosing spondylitis activity
title_sort serum amyloid a as a marker of ankylosing spondylitis activity
topic ankylosing spondylitis
hla-b27
saa
crp
esr
secondary amyloidosis
url https://mrj.ima-press.net/mrj/article/view/1230
work_keys_str_mv AT kvsakharova serumamyloidaasamarkerofankylosingspondylitisactivity
AT mvcherkasova serumamyloidaasamarkerofankylosingspondylitisactivity
AT shferdes serumamyloidaasamarkerofankylosingspondylitisactivity